Akrimax Pharmaceuticals, LLC FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Feb 17, 2016
  • No warning letters matched by name
Inspections 2 0 OAI
Recalls 0 0 Class I
Warning letters 0 None on file
510(k) clearances 0 None on file

Akrimax Pharmaceuticals, LLC has 0 FDA recalls, 2 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Akrimax Pharmaceuticals, LLC" is on file.

What these totals cover: FDA records filed under the name "Akrimax Pharmaceuticals, LLC" and its spelling variant "Akrimax Pharmaceuticals".

Latest inspection
Feb 17, 2016 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections2Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

Reviewing Akrimax Pharmaceuticals, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Akrimax Pharmaceuticals, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent FDA inspections

2 inspections from Aug 19, 2011 to Feb 17, 2016.

DateSiteProductClassificationFEI
Feb 17, 2016Cranford, NJDrugsNo Action Indicated (NAI)3007295270
Aug 19, 2011Cranford, NJDrugsNo Action Indicated (NAI)3007295270
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3007295270Cranford, NJ2Feb 17, 2016

Akrimax Pharmaceuticals, LLC and the FDA: common questions

Has Akrimax Pharmaceuticals, LLC received an FDA warning letter?

No FDA warning letter addressed to the name "Akrimax Pharmaceuticals, LLC" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Akrimax Pharmaceuticals, LLC received an FDA Form 483?

FDA has not published a Form 483 for "Akrimax Pharmaceuticals, LLC" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Akrimax Pharmaceuticals, LLC?

The most recent FDA inspection on file ended Feb 17, 2016 at Cranford, NJ and was classified NAI. FDA has 2 inspections of Akrimax Pharmaceuticals, LLC on file.

Need more than this page shows? Ask about Akrimax Pharmaceuticals, LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.